DNM1L and lung adenocarcinoma: Compared to that in patients without postoperative recurrence, those with recurrence had lung adenocarcinoma with increased expression of both DRP1 (Fig. 1B,C) and P(S616)‐DRP1 (Fig. 1E,F).